Stay updated with breaking news from Personalis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Personalis, Inc. announced today that data presented at the American Society for Clinical Oncology (ASCO) oral podium talks in Chicago, IL demonstrated that the Personalis NeXT Personal test had exceptional detection rates and performance for...
'Ultra-sensitive' cancer blood test is highly accurate in identifying which breast cancer patients will relapse The 'Personalis NeXT Personal® liquid biopsy' test uses whole genome sequencing
Bruce & Co. Inc. grew its holdings in Personalis, Inc. (NASDAQ:PSNL – Free Report) by 100.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 300,000 shares of the company’s stock after acquiring an additional 150,000 shares during the period. Bruce & Co. Inc. […]
FREMONT - Personalis, Inc. , a leader in advanced genomics for precision oncology, today announced that the Compensation Committee of its Board of Directors granted, on May 15, 2024, a non-qualified...
Personalis, Inc. , a leader in advanced genomics for precision oncology, today announced that the Compensation Committee of its Board of Directors granted, on May 15, 2024, a non-qualified stock...